Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76701 - 76725 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Tamoxifen	Approved Investigational	AIPL1	23746	downregulated	Tamoxifen results in decreased expression of AIPL1 mRNA	17p13.2	A21115
Tamoxifen	Approved Investigational	ANGPTL3	27329	downregulated	Tamoxifen results in decreased expression of ANGPTL3 mRNA	1p31.3	A20645
Tamoxifen	Approved Investigational	AP1S1	1174	downregulated	Tamoxifen results in decreased expression of AP1S1 mRNA	7q22.1	A20430 A20646
Tamoxifen	Approved Investigational	APBA3	9546	upregulated	Tamoxifen results in increased expression of APBA3 mRNA	19p13.3	A24383
Tamoxifen	Approved Investigational	APC2	10297	downregulated	Tamoxifen results in decreased expression of APC2 mRNA	19p13.3	A24383
Tamoxifen	Approved Investigational	APEX2	27301	upregulated	Tamoxifen results in increased expression of APEX2 mRNA	Xp11.21	A24383
Tamoxifen	Approved Investigational	AREG	374	upregulated	Tamoxifen results in increased expression of AREG mRNA	4q13.3	A21116
Tamoxifen	Approved Investigational	ASAH1	427	upregulated	Tamoxifen results in increased expression of ASAH1 mRNA	8p22	A20438 A20430 A20646
Tamoxifen	Approved Investigational	ASNS	440	upregulated	Tamoxifen results in increased expression of ASNS mRNA	7q21.3	A20430 A20646
Tamoxifen	Approved Investigational	ATF3	467	upregulated	Tamoxifen results in increased expression of ATF3 mRNA	1q32.3	A3616
Tamoxifen	Approved Investigational	ATF7IP	55729	upregulated	Tamoxifen results in increased expression of ATF7IP mRNA	12p13.1	A21112
Tamoxifen	Approved Investigational	ATP5B	506	upregulated	Tamoxifen results in increased expression of ATP5B mRNA	12q13.3	A21141
Tamoxifen	Approved Investigational	ATP6V0A1	535	upregulated	Tamoxifen results in increased expression of ATP6V0A1 mRNA	17q21.2	A24383
Tamoxifen	Approved Investigational	B2M	567	upregulated	Tamoxifen results in increased expression of B2M mRNA	15q21.1	A24384
Tamoxifen	Approved Investigational	BARD1	580	upregulated	Tamoxifen results in increased expression of BARD1 mRNA	2q35	A24383
Tamoxifen	Approved Investigational	BCL2	596	downregulated	Tamoxifen results in decreased expression of BCL2 mRNA	18q21.33	A24385
Tamoxifen	Approved Investigational	BCL6	604	upregulated	Tamoxifen results in increased expression of BCL6 mRNA	3q27.3	A3616
Tamoxifen	Approved Investigational	BIRC5	332	downregulated	Tamoxifen results in decreased expression of BIRC5 mRNA	17q25.3	A24386
Tamoxifen	Approved Investigational	BRPF1	7862	upregulated	Tamoxifen results in increased expression of BRPF1 mRNA	3p25.3	A24383
Tamoxifen	Approved Investigational	BST2	684	upregulated	Tamoxifen results in increased expression of BST2 mRNA	19p13.11	A24384
Tamoxifen	Approved Investigational	CALR	811	downregulated	Tamoxifen results in decreased expression of CALR mRNA	19p13.13	A21116
Tamoxifen	Approved Investigational	CBX3	11335	downregulated	Tamoxifen results in decreased expression of CBX3 mRNA	7p15.2	A21112
Tamoxifen	Approved Investigational	CCL20	6364	downregulated	Tamoxifen results in decreased expression of CCL20 mRNA	2q36.3	A21168
Tamoxifen	Approved Investigational	CCND1	595	downregulated	Tamoxifen results in decreased expression of CCND1 mRNA	11q13.3	A21116 A21175 A22732
Tamoxifen	Approved Investigational	CCNE1	898	upregulated	Tamoxifen results in increased expression of CCNE1 mRNA	19q12	A22730

Displaying entries 76701 - 76725 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability